top of page

More Sensitive Detection of KRAS Mutations in Plasma Samples

Updated: Jan 27




Droplet digital PCR is an attractive choice for rare mutation detection during liquid biopsy studies due to its powerful sensitivity, ease of use and data analysis, and generally lower price point than other common detection technologies such as next-generation sequencing. In this study, the NEAT Liquid Biopsy Kit was compared to a competitor kit using Bio-Rad ddPCR™ KRAS G12/G13 Screening Kit to detect KRAS mutations in plasma spiked with liquid biopsy standards at varying allele frequency.



Figure 1. Number of Droplets Positive for KRAS G12/G13 Mutations from 4 mL Spiked Plasma
Figure 1. Number of Droplets Positive for KRAS G12/G13 Mutations from 4 mL Spiked Plasma

TECHNICAL NOTE SKU 77XXX


Comentarios


bottom of page